AGP Executive Report
Last update: 9 hours agoCardiology Technology: Philips says MediReport’s reporting and workflow tools will strengthen its cardiovascular informatics portfolio and support more connected care. Rare-Disease Drugs: UK company Ambrose Healthcare has acquired Utrecht-based AM-Pharma for up to €161 million, adding an investigational treatment for hypophosphatasia, a rare bone disease. Dutch Care Accountability: Former residents of Huize Soria, a Dutch-funded youth home in Spain, describe severe abuse; experts call it systematic abuse and child torture. An investigation reports Dutch care providers and agencies continued sending children there despite warning signs. Caribbean Mental Health: The Netherlands and St. Maarten are developing plans for a mental health facility serving St. Maarten, Saba and St. Eustatius. Dutch officials also acknowledge gaps in psychiatric care for offenders in the Caribbean and are pursuing a regional forensic-care plan. Drug Safety: Illegal use of weight-loss drug retatrutide is reportedly rising in the Netherlands.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
